GLP-1 medications are considered first-line treatments for diabetes and obesity
PubMed Rosen, R.C., Diamond, L.E., Earle, D.C., Shadiack, A.M., & Molinoff, P.B
Regulatory agencies increasingly recognize the value of surrogate endpoints, adaptive trial designs, and biomarker-driven patient stratification, particularly in areas of high unmet need
You can feel confident that your care plan considers all aspects of your health, with Paloma Healths expertise offering a tailored approach to both thyroid and metabolic wellness
Although this has been found to be the case, it was also found that other preprocedural GI effects were observed with a higher incidence in GLP-1 RA users such as reduced gastric acidity, nausea, vomiting, dyspepsia, and abdominal distension (OR 15.1
"It was not lifestyle management versus GLP-1